Phareeclo SRL
0.8 FTEThe score of Phareeclo shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +16 % Total assets +77 % Headcount (avg FTE) -20 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Phareeclo's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 Aug 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 31 Dec 2023filed on 07 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 26 Aug 2022
Phareeclo's financial analysis
- Solvency43.4%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Phareeclo
Phareeclo's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0884.648.809
- VAT number
- BE0884648809
- Peppol
- Registered · 0208:0884648809 · as of 04 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Oct 2006
- Registered office
- 9900 Eeklo
- Size
- Micro · 0.8 FTE
- Latest accounts
- 2025 · filed on 21 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Phareeclo (SRL) has been based in Eeklo since 2006, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 4,214 € and equity of 449,127 €; its revenue is not published. With 0.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 43.4%, below the median of its sector (44.2%).
Companies similar to Phareeclo
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Vita Pharma Retail sale of pharmaceutical products Kontich · balance sheet €1.04m
- A-Cura Retail sale of pharmaceutical products Beringen · balance sheet €1.04m
- Medmex Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet €1.03m
- Farmacenter Retail sale of pharmaceutical products Overijse · balance sheet €1.04m
- Pharmacie Kindt Retail sale of pharmaceutical products Comines-Warneton · balance sheet €1.03m
- Pharmatoune Retail sale of pharmaceutical products Beersel · balance sheet €1.03m
- Aerts Pharma Retail sale of pharmaceutical products Zonhoven · balance sheet €1.04m
- Ixelles Pharma Retail sale of pharmaceutical products Ixelles · balance sheet €1.03m
Frequently asked questions about Phareeclo
What is the revenue of Phareeclo?
Phareeclo files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Phareeclo?
In Belgium, the VAT number is the company number prefixed with BE: BE0884648809 for Phareeclo, if the company is VAT-registered. Its company number (CBE) is 0884.648.809.
Where is the registered office of Phareeclo?
According to the CBE register, the registered office of Phareeclo is in 9900 Eeklo.
What is the equity of Phareeclo?
At the close of the 2025 financial year, the equity of Phareeclo amounts to 449,127 €, a solvency of 43.4% of total assets.
How many people work at Phareeclo?
0.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Phareeclo?
The register lists 2 active mandates at Phareeclo. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Phareeclo
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →